Crossmark

Liraglutide for the treatment of obesity among patients with hidradenitis suppurativa

Crossref DOI link: https://doi.org/10.1016/j.medcle.2023.11.004

Published Print: 2024-02

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Nicolau, Joana

Nadal, Antoni

Sanchís, Pilar

Pujol, Antelm

Masmiquel, Lluís

Nadal, Cristina
License Information

Text and Data Mining valid from 2024-02-01

stm-asf valid from 2024-02-01

stm-asf valid from 2024-02-01

stm-asf valid from 2024-02-01

stm-asf valid from 2024-02-01

stm-asf valid from 2024-02-01
More Information

This article is maintained by: Elsevier

Article Title: Liraglutide for the treatment of obesity among patients with hidradenitis suppurativa

Journal Title: Medicina Clínica (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.medcle.2023.11.004

Content Type: article

Copyright: © 2023 Elsevier España, S.L.U. All rights reserved.